Share:Bangladesh has detected the presence of the highly infectious Lambda variant of COVID-19 which was first identified in Peru last August and has spread to around 30 countries. The variant has the potential of spreading rapidly and is termed a “variant of interest” by the World Health Organization (WHO). -Bangladesh, China sign vaccine co-production dealThe Bangladeshi government signed a trilateral Memorandum of Understanding (MoU) with China’s Sinopharm and its local manufacturer Incepta Pharmaceuticals Ltd. for COVID-19 vaccine co-production in Bangladesh. “Together, we will build a Great Wall against COVID-19,” Chinese Ambassador to Bangladesh Li Jiming said at the event. Bangladesh has so far administered over 20 million vaccine doses to its citizens, including over 5 million second shots.

Source: The Nation August 17, 2021 04:18 UTC